BMY Focuses on Label Expansion of Drugs: Will This Revive Growth?Zacks Investment Research • 06/13/25
Dividend Harvesting Portfolio Week 223: $22,300 Allocated, $2,310.77 In Projected DividendsSeeking Alpha • 06/12/25
Bristol Myers Squibb Presents Data Across Targeted Protein Degradation Research Including CELMoD™ Agents and BCL6 Ligand-Directed Degrader at EHA 2025Business Wire • 06/12/25
Bristol Myers Squibb to Report Results for Second Quarter 2025 on July 31, 2025Business Wire • 06/12/25
Bristol-Myers Squibb Company (BMY) Presents at Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)Seeking Alpha • 06/11/25
Bristol Myers Squibb Presents Late-Breaking Data from Pivotal Phase 3 POETYK PsA-1 Trial Demonstrating Superiority of Sotyktu (deucravacitinib) Compared with Placebo in Adults with Psoriatic ArthritisBusiness Wire • 06/11/25
Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus royaltiesGlobeNewsWire • 06/10/25
BMY Collaborates for Oncology Drug: Will This Boost Its Portfolio?Zacks Investment Research • 06/06/25
Bristol-Myers And BioNTech Deal: Good For Both Parties, But One Is The Better InvestmentSeeking Alpha • 06/06/25
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCOCNBC • 06/03/25
Bristol Myers makes $11 billion deal with BioNTech to join the cancer-drug raceMarket Watch • 06/02/25
BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor TypesBusiness Wire • 06/02/25
Bristol Myers Loses 20.7% in 3 Months: Buy, Sell or Hold the Stock?Zacks Investment Research • 05/29/25
Bristol-Myers Squibb Company (BMY) Bernstein 41st Annual Strategic Decisions Conference (Transcript)Seeking Alpha • 05/28/25
Bristol-Myers Squibb's Painful Pullback Has Triggered Richer Dividend Story - Upgrade To BuySeeking Alpha • 05/28/25